# Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions

> **NCT03899298** · PHASE1 · NOT_YET_RECRUITING · sponsor: **R3 Stem Cell** · enrollment: 5000 (estimated)

## Conditions studied

- Orthopedic Disorder
- Neurologic Disorder
- Urologic Diseases
- Erectile Dysfunction
- Autoimmune Diseases
- Renal Failure
- Renal Insufficiency
- Kidney Diseases
- Cardiac Event
- Cardiomyopathies
- CHF
- Pulmonary Disease
- COPD
- Alzheimer Disease
- Stroke
- Neuropathy;Peripheral
- Arthritis

## Interventions

- **BIOLOGICAL:** Amniotic and Umbilical Cord Tissue Procedure

## Key facts

- **NCT ID:** NCT03899298
- **Lead sponsor:** R3 Stem Cell
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2019-09-01
- **Primary completion:** 2024-03-20
- **Final completion:** 2029-03-20
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2019-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03899298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03899298, "Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03899298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*